Supernus Pharmaceuticals, Inc. announced that on February 14, 2024, Tami T. Martin, R.N., Esq., the company?s Senior Vice President, Regulatory Affairs, notified Supernus Pharmaceuticals, Inc. of her retirement from the company effective May 3, 2024. The Company expects Roman Bradel, Ph.D. to join the Company in March 2024 as its Vice President, Regulatory Affairs reporting to Frank Mottola, the Company?s Senior Vice President, Quality, GMP Operations and IT.